SYNBIOTIC Launches Medical Cannabis Pastilles in Germany

SYNBIOTIC SE, a European leader in medical cannabis, announced the launch of cannabis pastilles in Germany. Developed with BOLDER Arzneimittel GmbH & Co KG and partner pharmacies over three years, these pastilles offer a new therapeutic option. With improved delivery and taste, they aim to overcome the disadvantages of current forms, such as dried flowers and extracts.

Daniel Kruse, SYNBIOTIC's Managing Director, emphasized the personalized and effective nature of these pastilles. They offer precise THC dosing and easy application, potentially setting new standards in cannabis-based medicine. Available only on prescription, they are produced in pharmacies according to patient needs.

Subsidaries WEECO Pharma GmbH and MH medical hemp GmbH will distribute the components to pharmacies. Börge Diessel of WEECO Pharma highlighted the timely expansion of the product range complemented by a robust pharmacy network.